Theriva Biologics, Inc. (TOVX) stock
TOVXNYSEPharmaceutical PreparationsFiscal year ends December 31
$0.14+0.00 (+2.86%)
Close on Nov 18, 2026Market cap $6.61MP/E –Yield –
Theriva Biologics revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
For fiscal 2011 it was $0, down 100.0% from the year before.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2011 | Dec 31, 2011 | $0 | -100.0% |
| FY2010 | Dec 31, 2010 | $2.61M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $0 | – |
| Q1 FY2026 | Mar 31, 2026 | $300.00K | – |
See a number that looks wrong?